
Ashvattas Life Sciences LLP
About Ashvattas Life Sciences LLP
Data last updated:
Ashvattas Life Sciences LLP is a limited liability partnership (LLP) based in Nashik, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 September 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAY-5221. Its GSTIN is 27ABWFA4241J1Z2 (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Rajat Gotulal Agrawal and Tilak Rahul Agrawal.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Pl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹10.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39.06 Lakh (net margin 3.9%) and EBITDA of ₹44.86 Lakh (EBITDA margin 4.4%).
As per MCA filings, the LLP has open charges of ₹3.5 Cr on record.
Ashvattas Life Sciences LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0056418).
Company details
Recognitions & Rankings of Ashvattas Life Sciences
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-23-0056418
Contact details
Ashvattas Life Sciences LLP's registered office is in Nashik, Maharashtra.
- Registered AddressPl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ashvattas Life Sciences LLP
FY 2023 filings availableAshvattas Life Sciences LLP reported revenue of ₹10.11 Cr (up 162% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 162% in the latest year. EBITDA rose 49% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ||
| Other Income | ||
| Total Income | ||
| Purchases and Direct Costs | ||
| Personnel Expenses | ||
| Administrative Expenses | ||
| Interest | ||
| Depreciation | ||
| Total Expenses | ||
| Profit Before Tax | ||
| Tax | ||
| Profit After Tax | ₹39.06 Lakh | |
| Profit Transferred to Partners | ||
| Assets and Liabilities | ||
| Partners' Contribution | ||
| Reserves and Surplus | ||
| Secured Loans | ||
| Unsecured Loans | ||
| Trade Payables | ||
| Other Liabilities and Provisions | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Loans and Advances | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | 3.9% | |
| Return on Partners' Funds | ||
| Return on Assets | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Debt to Partners' Funds | ||
| Interest Coverage | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Turnover Growth | ||
| Profit Growth | ||
To see the full financial statements and ratios of Ashvattas Life Sciences LLP, buy the company report.
Designated partners of Ashvattas Life Sciences LLP
Ashvattas Life Sciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajat Gotulal Agrawal | Designated Partner | 09 Sep 2021 | 5 Years 1 Months | Current |
| Tilak Rahul Agrawal | Designated Partner | 01 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Ashvattas Life Sciences LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dmcare Pharma Private Limited | ₹10.19 Cr (FY 2025) | 130.0% | Ahmedabad, Gujarat, India | |||
| PMV Lifescience Private Limited | ₹10.19 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| Floreat Medica Private Limited | ₹10.19 Cr (FY 2025) | 4.0% | Angamaly, Kerala, India | |||
| R.G. Pharma Healthcare Private Limited | ₹10.14 Cr (FY 2025) | 12.0% | Jammu, Jammu and Kashmir, India | |||
| Zen Bio Tech Private Limited | ₹10.13 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Ashvattas Life Sciences LLPthis company | ₹10.11 Cr (FY 2023) | ₹39.06 Lakh | 3.9% | 162.0% | Nashik, Maharashtra, India | |
| Saturn Formulations Private Limited | ₹10.09 Cr (FY 2024) | 10.0% | Chandigarh, India | |||
| H.L.Healthcare Private Limited | ₹10.08 Cr (FY 2024) | -16.0% | Jalandhar, Punjab, India | |||
| Vaividhya Lifescience Private Limited | ₹10.03 Cr (FY 2025) | 37.0% | Kadi, Gujarat, India | |||
| Lustre Pharmaceuticals Private Limited | ₹10.03 Cr (FY 2025) | 8.0% | Ahmedabad, Gujarat, India | |||
| Medorganics India Private Limited | ₹10.02 Cr (FY 2024) | 15.0% | Mangalore, Karnataka, India |
To see the full peer comparison of Ashvattas Life Sciences LLP, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jan 2025 | 101035172 | State Bank of India | ₹3.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ashvattas Life Sciences LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ashvattas Life Sciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ashvattas Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABWFA4241J1Z2 | Maharashtra | Active | 15 Dec 2021 |
To see the full GST registrations and return filing status of Ashvattas Life Sciences LLP, buy the company report.
Recent activity
Ashvattas Life Sciences LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Sudhir Namdeo Dhivare ceased to be Designated Partner on 01 Apr 2024.
Frequently asked questions
Ashvattas Life Sciences is an active limited liability partnership based in Nashik, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 09 September 2021 (5+ years old) and is registered under LLPIN AAY-5221.
Ashvattas Life Sciences has 2 current designated partners:
- Rajat Gotulal Agrawal - Designated Partner
- Tilak Rahul Agrawal - Designated Partner
The latest financial statements of Ashvattas Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ashvattas Life Sciences is 27ABWFA4241J1Z2, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Ashvattas Life Sciences is AAY-5221. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Ashvattas Life Sciences was incorporated on 09 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ashvattas Life Sciences by revenue are Dmcare Pharma Private Limited, PMV Lifescience Private Limited, Floreat Medica Private Limited, R.G. Pharma Healthcare Private Limited, Zen Bio Tech Private Limited and 5 more, all in the Pharma industry (Formulations).
Sudhir Namdeo Dhivare ceased to be Designated Partner on 01 Apr 2024. Tilak Rahul Agrawal was appointed as Designated Partner on 01 Apr 2024. Rajat Gotulal Agrawal was appointed as Designated Partner on 09 Sep 2021.
Yes, Ashvattas Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Ashvattas Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-23-0056418).
The registered office of Ashvattas Life Sciences is at Pl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101.

